» start page

 » tutorial / help

 » documentation
    
publications
    
about / tech info

 » personal annotations
    
load /save

 » quiz mode

 » authors / contact

 » Contents listing
    
short long WHO

  Normal breast
  Non-neoplastic lesions
  Benign epithelial
   proliferations
  Fibro/myoepithelial
   tumors

  Tumors of the nipple

  Lobular neoplasia

  Intraductal prolifera-
   tive lesions

  Invasive epithelial
   tumors

    
IDC ILC Other

  Mesenchymal tumors

  Hematopoetic and
   metastatic tumors

  IH-stainings, TMAs,
   FISH and CISH

Metastatic IDC

up one level


Axillary lymph node metastasis
Axillary lymph nodes represent the first site of metastatic dissemination. Histologically axillary metastases vary from massive metastatic growth destroying the lymph node architecture to small focuses presenting with individual cytokeratin positive cells or cell clusters. The size of the carcinoma foci (<0.2mm , 0.2-2mm, >2mm) is used in the current version of TNM classification.

Sentinel lymph node metastasis
Sentinel lymph nodes are located first in the axillary or parasternal lymphatic drainage tree. The sentinel nodes are the first lymph nodes to become metastasized from breast tumors, and when the sentinel nodes are found to be carcinoma-free, upper nodes need not be surgically removed.

In sentinel node surgery, pathologists examine the sentinel node(s) intraoperatively using frozen sections. Identification of small carcinoma foci with toluidine blue or HE stainings is difficult and may lead to false negative diagnoses in up to 10-20% of cases. Ultrarapid pan-cytokeratin immunostaining is a promising new aid in the intraoperative sentinel node diagnostics.

Toluidine blue

Intraoperative
pan-cytokeratin

Paraffin-control
/HE

Paraffin-control
/pan-cytokeratin


All material on this website is protected by copyright. By accessing or downloading contents
from this website, you expressly agree and consent to our terms and conditions.